Stocktoria
OSR Health, Inc. OSRH
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2023-02-10
OSR Health, Inc. financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.9M | $3.5M | — | — | — |
| Gross profit | $592,905 | $811,236 | — | — | — |
| R&D expense | $318,446 | $161,155 | — | — | — |
| SG&A expense | $18.9M | $12.5M | $1.8M | $35,388 | $3,308 |
| Operating income | -$18.3M | -$11.7M | -$1.8M | -$35,388 | -$3,308 |
| Income tax | -$1.8M | -$1.6M | $540,811 | — | — |
| Net income | — | -$2.4M | $403,780 | -$35,388 | -$3,308 |
| EPS (diluted) | $-0.80 | $-4.79 | $0.05 | $-0.01 | — |
| Operating cash flow | -$4.3M | -$1.8M | -$818,766 | -$4,235 | -$461 |
| Cash & equivalents | $1.7M | $341,543 | $15,419 | $124,501 | $4,757 |
| Inventory | $196,432 | $922,107 | — | — | — |
| Total assets | $171.2M | $175.2M | $36.6M | $1.2M | $705,087 |
| Total liabilities | $44.2M | $32.0M | $4.1M | $1.3M | $707,207 |
| Shareholders' equity | $127.0M | $143.2M | $153.5M | -$37,508 | -$2,120 |
Growth · year-over-year · Revenue CAGR -17.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | -17.7% | — | — | — | — |
| Net income growth | — | -697.1% | — | — | — |
| EPS growth | — | -9680.0% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.